European Journal of Cancer
Volume 45, Issue 17 , Pages 2930-2934 , November 2009

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

Received 21 July 2009 ,Accepted 20 August 2009.

References 

  1. Pikaar A, Nortier JWR, Griffioen G, Vasen HFA. Desmoid tumours in patients with familial adenomatous polyposis (FAP). NTvG. 2002;146(29):1355–1359
  2. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18:6615–6620
  3. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoids tumors. J Clin Oncol. 2007;25(13):1785–1791
  4. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol. 2006;24:11–12
  5. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004;100:612–620
  6. Weiss AJ, Horowiz S, Lackman RD. Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol. 1999;22:193–195
  7. Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer. 2003;97:134–135
  8. Gega M, Yanagi H, Yoshikawa R, et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoids tumors in association with familial adenomatous polyposis. J Clin Oncol. 2006;24:102–105
  9. Poritz LS, Blackstein M, Berk T, Gallinger S, McLeod RS, Cohen Z. Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoids tumors. Dis Colon Rectum. 2001;44:1268–1273
  10. Wehl G, Rossler J, Otten JE, et al. Response of progressive fibromatosis to therapy with liposomal doxorubicin. Onkologie. 2004;27(6):526–552
  11. Van Dalen EC, Michiels EMC, Caron HN, Kremer LCM. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev 2006; Issue 4. Art. No.: CD005006. doi: 10.1002/14651858.CD005006.pub2.
  12. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247
  13. Pilz T, Pilgrim TB, Bisogno G, et al. Chemotherapy in fibromatoses of childhood and adolescence: results from the cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP). Klin Padiatr. 1999;211:291–295
  14. Skapec SX, Hawk BJ, Hoffer FA, et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol. 1998;16:3021–3027
  15. Heinrich MC, McArthur G GA, Demetri GD, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006;24:1195–1203

PII: S0959-8049(09)00653-4

doi: 10.1016/j.ejca.2009.08.016

European Journal of Cancer
Volume 45, Issue 17 , Pages 2930-2934 , November 2009

Article Tools